Rtw Investments »

Abivax SA F shares owned by Rtw Investments

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $30M 350k 84.90

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Argenx Se Sponsored Adr (ARGX)
Avidity Biosciences Ord (RNA)
Ptc Therapeutics I (PTCT)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
Akero Therapeutics (AKRO)
Uniqure Nv SHS (QURE)
Penumbra (PEN)
RadNet (RDNT)
Merus N V (MRUS)
Tarsus Pharmaceuticals (TARS)
Stryker Corporation (SYK)
Immunocore Hldgs Ads (IMCR)

View all positions for Rtw Investments

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F